Drugs / R lipoic acid
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00676156 Comparator | Dec 2005 → Feb 2008 | multiple sclerosis | Oregon Health and Science University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R lipoic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00676156 ↗ |
| Route | Oral | “A single oral dose of 1200mg R enantiomer LA will be administered.” NCT00676156 ↗ |